Cleared Traditional

K023015 - CARDIS

K023015 is an FDA 510(k) clearance for CARDIS, manufactured by Schwarzer GmbH. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K023015 · Schwarzer GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2002
Decision
15d
Days
Class 2
Risk

K023015 is an FDA 510(k) clearance for the CARDIS. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Schwarzer GmbH (Munich, DE). The FDA issued a Cleared decision on September 25, 2002 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Schwarzer GmbH devices

FDA 510(k) Submission Details - K023015

510(k) Number K023015 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2002
Decision Date September 25, 2002
Days to Decision 15 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 125d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 346
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K023015.
T-WAVE ALTERMANS (TWA) ALGORITHM OPTION
K023380 · General Electric Medical Systems Information Techn · Dec 2002
RADIANALYZER, MODEL 12710
K022188 · Radi Medical Systems AB · Oct 2002
QIVA
K021495 · Pie Medical Imaging BV · Oct 2002
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
MAC-LAB/CARDIOLAB EP/COMBOLAB
K021366 · General Electric Medical Systems Information Techn · Jul 2002
PHYSIOLOG, SERIES 95000
K013032 · Camtronics, Ltd. · Jun 2002